91 related articles for article (PubMed ID: 30220069)
21. Multi-omics analysis defines 5-fluorouracil drug resistance in 3D HeLa carcinoma cell model.
Wang L; Wang X; Wang T; Zhuang Y; Wang G
Bioresour Bioprocess; 2021 Dec; 8(1):135. PubMed ID: 38650282
[TBL] [Abstract][Full Text] [Related]
22. Unraveling mitotic protein networks by 3D multiplexed epitope drug screening.
Maier LJ; Kallenberger SM; Jechow K; Waschow M; Eils R; Conrad C
Mol Syst Biol; 2018 Aug; 14(8):e8238. PubMed ID: 30104419
[TBL] [Abstract][Full Text] [Related]
23. Mapping cellular-scale internal mechanics in 3D tissues with thermally responsive hydrogel probes.
Mok S; Al Habyan S; Ledoux C; Lee W; MacDonald KN; McCaffrey L; Moraes C
Nat Commun; 2020 Sep; 11(1):4757. PubMed ID: 32958771
[TBL] [Abstract][Full Text] [Related]
24. Dynamic microphysiological system chip platform for high-throughput, customizable, and multi-dimensional drug screening.
Zhu Y; Jiang D; Qiu Y; Liu X; Bian Y; Tian S; Wang X; Hsia KJ; Wan H; Zhuang L; Wang P
Bioact Mater; 2024 Sep; 39():59-73. PubMed ID: 38800720
[TBL] [Abstract][Full Text] [Related]
25. Initiation, Expansion, and Cryopreservation of Human Primary Tissue-Derived Normal and Diseased Organoids in Embedded Three-Dimensional Culture.
Clinton J; McWilliams-Koeppen P
Curr Protoc Cell Biol; 2019 Mar; 82(1):e66. PubMed ID: 30265443
[TBL] [Abstract][Full Text] [Related]
26. EpCAM
Wang L; Dorn P; Simillion C; Froment L; Berezowska S; Tschanz SA; Haenni B; Blank F; Wotzkow C; Peng RW; Marti TM; Bode PK; Moehrlen U; Schmid RA; Hall SRR
Am J Physiol Lung Cell Mol Physiol; 2020 Nov; 319(5):L794-L809. PubMed ID: 32726135
[TBL] [Abstract][Full Text] [Related]
27. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients.
Chen JH; Chu XP; Zhang JT; Nie Q; Tang WF; Su J; Yan HH; Zheng HP; Chen ZX; Chen X; Song MM; Yi X; Li PS; Guan YF; Li G; Deng CX; Rosell R; Wu YL; Zhong WZ
Thorac Cancer; 2020 Aug; 11(8):2279-2290. PubMed ID: 32633046
[TBL] [Abstract][Full Text] [Related]
28. Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine.
Dijkstra KK; Monkhorst K; Schipper LJ; Hartemink KJ; Smit EF; Kaing S; de Groot R; Wolkers MC; Clevers H; Cuppen E; Voest EE
Cell Rep; 2020 May; 31(5):107588. PubMed ID: 32375033
[TBL] [Abstract][Full Text] [Related]
29. A comprehensive review on 3D tissue models: Biofabrication technologies and preclinical applications.
Xie R; Pal V; Yu Y; Lu X; Gao M; Liang S; Huang M; Peng W; Ozbolat IT
Biomaterials; 2024 Jan; 304():122408. PubMed ID: 38041911
[TBL] [Abstract][Full Text] [Related]
30. Human Lung Organoids-A Novel Experimental and Precision Medicine Approach.
Kühl L; Graichen P; von Daacke N; Mende A; Wygrecka M; Potaczek DP; Miethe S; Garn H
Cells; 2023 Aug; 12(16):. PubMed ID: 37626876
[TBL] [Abstract][Full Text] [Related]
31. Patient-derived organoids of lung cancer based on organoids-on-a-chip: enhancing clinical and translational applications.
Zeng X; Ma Q; Li XK; You LT; Li J; Fu X; You FM; Ren YF
Front Bioeng Biotechnol; 2023; 11():1205157. PubMed ID: 37304140
[TBL] [Abstract][Full Text] [Related]
32. Evaluating the efficacy and cardiotoxicity of EGFR-TKI AC0010 with a novel multifunctional biosensor.
Jiang D; Wei X; Zhu Y; Qiu Y; Liu X; Kong L; Li F; Liu J; Zhuang L; Wan H; Ying K; Wang P
Microsyst Nanoeng; 2023; 9():57. PubMed ID: 37180453
[TBL] [Abstract][Full Text] [Related]
33. Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation.
Iqbal MJ; Javed Z; Herrera-Bravo J; Sadia H; Anum F; Raza S; Tahir A; Shahwani MN; Sharifi-Rad J; Calina D; Cho WC
Cancer Cell Int; 2022 Nov; 22(1):354. PubMed ID: 36376956
[TBL] [Abstract][Full Text] [Related]
34. Electrodynamic assisted self-assembled fibrous hydrogel microcapsules: a novel 3D
Bhattarai SR; Saudi S; Khanal S; Aravamudhan S; Rorie CJ; Bhattarai N
RSC Adv; 2021 Jan; 11(9):4921-4934. PubMed ID: 35424445
[TBL] [Abstract][Full Text] [Related]
35. Technological Advances in Tumor-On-Chip Technology: From Bench to Bedside.
Bērziņa S; Harrison A; Taly V; Xiao W
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439345
[TBL] [Abstract][Full Text] [Related]
36. [Research advances of high-throughput cell-based drug screening systems based on microfluidic technique].
Liang Y; Pan J; Fang Q
Se Pu; 2021 Jun; 39(6):567-577. PubMed ID: 34227317
[TBL] [Abstract][Full Text] [Related]
37. In-Line Analysis of Organ-on-Chip Systems with Sensors: Integration, Fabrication, Challenges, and Potential.
Fuchs S; Johansson S; Tjell AØ; Werr G; Mayr T; Tenje M
ACS Biomater Sci Eng; 2021 Jul; 7(7):2926-2948. PubMed ID: 34133114
[TBL] [Abstract][Full Text] [Related]
38. Thermosensitive and Conductive Hybrid Polymer for Real-Time Monitoring of Spheroid Growth and Drug Responses.
Lin ZT; Gu J; Wang H; Wu A; Sun J; Chen S; Li Y; Kong Y; Wu MX; Wu T
ACS Sens; 2021 Jun; 6(6):2147-2157. PubMed ID: 34014658
[TBL] [Abstract][Full Text] [Related]
39. Electrochemical Sensing in 3D Cell Culture Models: New Tools for Developing Better Cancer Diagnostics and Treatments.
Oliveira M; Conceição P; Kant K; Ainla A; Diéguez L
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33803738
[TBL] [Abstract][Full Text] [Related]
40. Potential of Drug Efficacy Evaluation in Lung and Kidney Cancer Models Using Organ-on-a-Chip Technology.
Hwang SH; Lee S; Park JY; Jeon JS; Cho YJ; Kim S
Micromachines (Basel); 2021 Feb; 12(2):. PubMed ID: 33669950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
